Table 5.
Multivariate analysis for relapse, OS, LFS, and GRFS.
| Variable | CIR | OS | LFS | GRFS | ||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| Risk stratification | 3.124 (1.338–7.293) | 0.008 | 0.386 (0.177–0.842) | 0.017 | 0.398 (0.189–0.839) | 0.015 | 0.500 (0.267–0.933) | 0.029 |
| Disease status before HSCT | 1.550 (0.452–5.309) | 0.485 | 1.392 (0.465–4.162) | 0.554 | 1.025 (0.382–2.750) | 0.961 | 0.728 (0.309–1.716) | 0.468 |
| Donor/recipient sex match | 0.258 (0.077–0.861) | 0.028 | 0.496 (0.202–1.218) | 0.126 | 0.455 (0.187–1.108) | 0.083 | 0.721 (0.352–1.479) | 0.372 |
| Conditioning regimen | 0.513 (0.234–1.125) | 0.096 | 2.402 (1.123–5.137) | 0.024 | 2.047 (1.009–4.154) | 0.047 | 1.836 (1.011–3.334) | 0.046 |
CIR, cumulative incidence of relapse; OS, overall survival; LFS, leukemia-free survival; GRFS, graft-versus-host disease-free relapse-free survival; HR, hazard ratio; CI, confidence interval; HSCT, hematopoietic stem cell transplantation.